PocDoc secures £5m funding to grow digital diagnostics business

Health tech startup PocDoc has raised £5 million in pre-series A round to help grow its app-based platform that delivers end-to-end digital pathways for the assessment, diagnosis and treatment of disease.

The conclusion of the funding round brings the total pre-A funding raised by PocDoc to more than £10m, with the firm raising £5m from MMC Ventures, Molten VC and Simplyhealth Ventures in its most recent funding round.

A fourth major investor joining in this round is KHP Ventures, an NHS-anchored venture fund, which invests in health tech innovators and supports the adoption of transformative solutions at scale across digital health and med tech.

The firm said that the new investment will support the company’s continued rapid growth, fuelled by its growing list of pharmacy, retail, and corporate partnerships, as well as its deepening relationships with the NHS across the UK.

Steve Roest, chief executive and cofounder at PocDoc, said the heavily oversubscribed investment round is “a major endorsement” of the startup’s technology and journey to date.

“We are delighted to see such healthy interest in our vision of revolutionising access to screening from the investment community and we’re thrilled to have Molten Ventures, MMC Ventures, and Simplyhealth Ventures investing.

“The inclusion of KHP Ventures as a fund backed by NHS institutions is a clear signal of our NHS traction and alignment with overall NHS priorities – we couldn’t be happier that they’re investing in our journey.

“Prevention is the lifeblood of our business. Through our screening technology we believe we can drive a fundamental shift in how we treat chronic diseases, helping people detect problems earlier and faster, get treatment sooner, and, in doing so, reduce the burden on under pressure health services.

“As proven by our growing list of partnerships in both public and private sectors and the tens of thousands of people that have already benefitted from PocDoc’s diagnostics, we’re already making a massive impact,” Roest said.

He added that the firm has new tests for metabolic, kidney and whole body health in the pipeline, and plans to scale into new international markets in 2025.

PocDoc’s platform uses machine learning, data and process integration, dynamic workflows, clinical teams and real-time alerting, to enable patients to receive a full health assessment and critical follow-on services, including speaking to a clinician, notifying GPs, sending results to a patient record and providing real-time treatment options.

Tim Irish, partner at KHP Ventures, said: “At KHP Ventures, our focus is on investing in innovators and technologies that are going to deliver the transformation required to deliver the best possible outcomes for patients, staff and health systems, starting with the NHS.

“PocDoc is demonstrating excellent traction and we’re looking forward to working with Steve, Vlad, Kiran, and the team on the next phase of their growth journey.”

In summer 2024, PocDoc announced the launch of a new ‘Healthy Heart Check’ feature, a point-of-care diagnostic test for cardiovascular disease that lets patients see their results immediately in an app.

To date, the Healthy Heart Check service has been used by tens of thousands of patients across the country and 97% of patients surveyed said that they would recommend the service to a family member or friend.